Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Candid Therapeutics Plans to Initiate Multiple Phase 2 Studies Following Promising Clinical Data of T-cell Engagers in Autoimmune Diseases
-
The N2 Company Celebrates 10 Years of Giving, $30 Million Donated to Fight Human Trafficking
-
PlusAI on Track to Launch Factory-Built Commercial Autonomous Trucks Next Year
-
Tisento Therapeutics Completes Enrollment in PRIZM, a Global Phase 2b Study of Zagociguat for the Treatment of MELAS
-
Atea Pharmaceuticals to Highlight 2026 Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference
-
Vizgen Announces $48 Million Financing
-
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook
-
JOYBEES WINS TWO GLOBAL FOOTWEAR AWARDS
-
NIQ and Kodiak Announce Retail Measurement Agreement to Drive Breakfast Category Growth
-
Lantronix to Attend 28th Annual Needham Growth Conference on Jan. 13, 2026
-
RELEX Solutions Launches Deal Management for Smarter Collaborative Promotion Planning
-
Lumexa Imaging Achieves Record De Novo Expansion in 2025
-
Tanger Announces Pricing of Upsized Exchangeable Senior Notes Offering
-
K1x and Juno Announce Strategic Partnership to Provide Industry-Leading Tax Automation
-
U.S. Army Selects Striveworks for AI Test and Evaluation
-
Virometix AG Announces Positive Data from Phase 1 Trial of V-212, a Fully Synthetic, Serotype-Independent Vaccine Development Candidate for the Prevention of Pneumococcal Disease
-
SpliceBio Initiates Dose-Expansion Portion of Phase 1/2 ASTRA Clinical Trial for SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
-
Miller Lite Unveils New Creative Platform, "Legendary Moments Start with a Lite," Starring Christopher Walken
-
Concord Appoints Chris Baker as Executive Chairman
-
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
-
AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference
-
Aurora Mobile Congratulates Zhipu on Successful Hong Kong Listing
-
Brunswick Exploration Announces Inferred Mineral Resource of 52.2Mt at 1.08% Li2O at Mirage with Additional Exploration Target
-
Surge Copper Advances Berg Toward Pre-Feasibility with Successful 2025 Drilling and Data Validation Program
-
Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities
-
Woof Gang Achieves Record Growth in 2025
-
Anika Therapeutics Announces Leadership Transition
-
ONAR Completes Sale of Certain Legacy Assets in a Secured $1.5 Million Seller-Financed Transaction
-
Transpire Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026
-
Cullinan Therapeutics Provides Corporate Update and Highlights Anticipated 2026 Milestones
-
Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit
-
Troilus Delivers on Key Development Milestones in 2025 and Enters a Pivotal Transition Year in 2026
-
Kinross to provide update on Round Mountain Phase X, Kettle River-Curlew and Bald Mountain Redbird 2 projects
-
Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases
-
AAVantgarde to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Sagimet Biosciences Announces Poster Presentation at the 10th Annual MASH-TAG 2026 Conference
-
Fixing of coupon rates – Nykredit Realkredit A/S
-
Net Asset Value(s)
-
Enara Bio Enters 2026 with Dark Antigen Licensing to Boehringer Ingelheim, Appointment of Chief Medical Officer and Plans to Advance DARKFOX T-cell Engager into First-in-Human Studies
-
AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)
-
Antag Therapeutics demonstrates compelling potential of its novel GIPR antagonist for obesity, reporting excellent tolerability in Phase 1 and enhanced weight loss in amylin combination study
-
CMR Surgical receives CE Mark for use of Versius in paediatric surgery
-
BitMEX Report Finds Crypto Perpetuals Enter Post-Yield Era
-
Datavault AI Expands IBM Collaboration to Deploy Enterprise-Grade AI at the Edge with Available Infrastructure's SanQtum AI Platform
-
Inventus Secures $2.1 Million Gold Pre-Payment and Provides Exploration Update
-
Indivior Provides Full-Year 2026 Financial Guidance and Business Update
-
Ascend Advanced Therapies - ABL Inc. Further Strengthens Executive Team as It Drives Forward an Ambitious Growth Strategy
-
AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield(TM) for AI-Powered Holter Analysis
-
Bridgehead Earns ISO/IEC 27001:2022 Certification, Strengthening Global Information Security Standards
